scholarly journals Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma

2021 ◽  
pp. 987-993
Author(s):  
John M. Rieth ◽  
Randy Chris Bowen ◽  
Mohammed M. Milhem ◽  
H. Culver Boldt ◽  
Elaine M. Binkley

We describe the case of a 69-year-old woman who presented with a decline in vision in the left eye and was found to have a choroidal lesion with clinical and echographic features concerning for primary uveal melanoma. Systemic imaging identified numerous metastases to the liver, kidneys, paratracheal lymph nodes, lung, and brain. The hepatic lesion was biopsied, and genetic analysis identified a Val600Glu (c.1799T&#x3e;A) <i>BRAF</i> mutation, consistent with a cutaneous primary malignancy, although no primary tumor was identified. This case highlights that metastasis to the choroid is a rare presentation of nonuveal melanoma that can mimic primary uveal melanoma. Genetic analysis of tumor tissue can identify the origin of the melanoma and guide treatment options. Systemic imaging should be performed prior to intervention for choroidal neoplasms.

2020 ◽  
Vol 44 (4) ◽  
Author(s):  
Krystallenia I. Alexandraki ◽  
Marina Tsoli ◽  
Georgios Kyriakopoulos ◽  
Anna Angelousi ◽  
Georgios Nikolopoulos ◽  
...  

1981 ◽  
Vol 71 (12) ◽  
pp. 1431-1434 ◽  
Author(s):  
S. RAJU INDUPALLI ◽  
AGOP Y. BEDIKIAN ◽  
GERALD P. BODEY

1994 ◽  
Vol 87 (10) ◽  
pp. 1419-1426
Author(s):  
Katsuhiko FUKAMOTO ◽  
Masafumi NAKAGAWA ◽  
Naoyuki KONO

2021 ◽  
Vol 11 ◽  
Author(s):  
Murilo Bonatelli ◽  
Isabella Fernandes Fornari ◽  
Priscila Neves Bernécule ◽  
Lara Esquiapatti Pinheiro ◽  
Ricardo Filipe Alves Costa ◽  
...  

IntroductionCancer of unknown primary origin (CUP) is defined as metastatic cancer without identification of the primary site. Considering that only 15–20% of patients with CUP show a favorable outcome, identifying biomarkers may help improve the clinical management of patients who do not respond well to conventional therapies. In this context, the study of the metabolic profile of CUP may pave the way to establish new biomarkers and/or therapeutic targets; therefore, this study aimed to characterize the expression of metabolism-related proteins in CUP.Materials and MethodsThe expression of monocarboxylate transporters MCT1, MCT2 and MCT4, their chaperone CD147, the glucose transporter GLUT1 and the pH regulator CAIX was evaluated by immunohistochemistry in a series of 118 CUP patients, and the results were associated with the available clinicopathological information.ResultsThe metabolism-related proteins MCT1, MCT4, CD147, GLUT1 and CAIX were expressed in a critical portion of the CUP (approximately 20 to 70%). MCT1 and CD147 were both more frequently expressed in cases with lymph nodes as metastasis dominant sites (p = 0.001) as well as in samples from lymph nodes (p &lt;0.001 and p = 0.002, respectively), while MCT1 expression was more frequently expressed in squamous cell carcinomas (p = 0.045). A higher overall survival was observed in patients with tumors positive for GLUT1 and CAIX expression (p = 0.011 and p = 0.041, respectively), but none of the proteins was an independent prognostic factor for overall survival in multivariable analysis.ConclusionThe results suggest that a portion of CUPs present a hyperglycolytic phenotype, which is associated with higher overall survival.


2005 ◽  
Vol 11 (1) ◽  
Author(s):  
Rafet Koca ◽  
Yucel Ustundag ◽  
Eksal Kargi ◽  
Gamze Numanoglu ◽  
H Cevdet Altinyazar

2009 ◽  
Vol 135 (10) ◽  
pp. 1024-1029 ◽  
Author(s):  
J. D. Waltonen ◽  
E. Ozer ◽  
N. C. Hall ◽  
D. E. Schuller ◽  
A. Agrawal

1991 ◽  
Vol 37 (6) ◽  
pp. 1127-1131 ◽  
Author(s):  
Heather J Cain ◽  
Peter R Pannall ◽  
Dusan Kotasek ◽  
Robert J Norman

Abstract A 38-year-old man with a metastatic gonadotropin-secreting tumor of unknown primary origin presented with both clinical and biochemical findings of hyperthyroidism in association with markedly increased concentrations of human choriogonadotropin (hCG) in plasma. After chemotherapy, the concentrations of both hCG and free thyroxin decreased and the patient became euthyroid. We discuss the rare occurrence of this presumably hCG-driven hyperthyroidism in men and compare it with the relatively more common eumetabolic hyperthyroidism associated with choriocarcinoma in women.


Sign in / Sign up

Export Citation Format

Share Document